Key failure to deliver metrics for Revance Therapeutics:
Last SEC data release: 2024-11-29
Last 15 days FTD volume: N/A
Last 3 months FTD volume: A$0.26 M
Last year FTD volume: A$0.26 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Revance Therapeutics (RVNC) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014
Volume in USD (price x number of shares), data since 2014
Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2024
A$6.83 M
-84.89%
2023
A$45.25 M
383.15%
2022
A$9.36 M
-6.12%
2021
A$9.97 M
-56.82%
2020
A$23.1 M
668%
2019
A$3 M
-97.15%
2018
A$0.10 B
815.52%
2017
A$11.51 M
5.25%
2016
A$10.93 M
-46.65%
2015
A$20.5 M
-9.25%
2014
A$22.59 M
FTD volume in the last 3 months for similar companies or competitors